Incidence and medical complications of COVID-19 in the total laryngectomy population: A population-based study. (April 2023)

• Record Type: Journal Article
• Authors: Patel, Nilam D.; Cabrera, Claudia I.; Fowler, Nicole M.; Li, Shawn; Thuener, Jason E.; Lavertu, Pierre; Teknos, Theodoros N.; Rezaee, Rod P.; Tamaki, Akina
• Is Part Of: Oral oncology. Volume 139(2023)
• Publication Date: 2023-04
• Subjects: Total laryngectomy -- Coronavirus-19 -- Laryngeal cancer -- Hypopharyngeal cancer -- COVID-19; Mouth -- Cancer -- Periodicals; Mouth -- Tumors -- Periodicals; Mouth Diseases -- Periodicals; Mouth Neoplasms -- Periodicals; Bouche -- Cancer -- Périodiques; Bouche -- Tumeurs -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9943105
• DOI: 10.1016/j.oraloncology.2023.106353
• Languages: English
• ISSNs: 1368-8375

Abstract

Highlights: Laryngeal cancer patients have increased incidence of acquiring COVID-19. Total laryngectomy may increase susceptibility to COVID-19. COVID-19 in total laryngectomy patients may increase risk of complications. Abstract: Objectives: Laryngeal and hypopharyngeal cancers treated with total laryngectomy (TL) may provide a unique avenue for COVID-19 to infect cancer patients. The objective of this investigation was to identify incidence of COVID-19 infection and potential complications in TL patients. Materials and Methods: Data was extracted from TriNetX COVID-19 research network from from 2019 to 2021 and ICD-10 codes were utilized to query for laryngeal or hypopharyngeal cancer, and outcomes of interest. Cohorts were propensity score-matched based on demographics and co-morbidities. Results: A query of active patients in TriNetX from January 1, 2019 to December 31, 2021 identified 36, 414 patients with laryngeal or hypopharyngeal cancer out of the 50, 474, 648 active patients in the database. The overall COVID-19 incidence in the non-laryngeal or hypopharyngeal cancer population was 10.8% compared to 18.8% (p < 0.001) in the laryngeal and hypopharyngeal cancer group. Those who underwent TL had a statistically significant increased incidence of acquiring COVID-19 (24.0%) when compared to those without TL (17.7%) (p < 0.001). TL patients with COVID-19 had a higher risk of developing pneumonia RR (risk ratio) 1.80 (1.43, 2.26), death 1.74 (1.41, 2.14), ARDS 2.42 (1.16, 5.05), sepsis 1.77 (1.37, 2.29), shock 2.81 (1.88, 4.18), respiratory failure 2.34 (1.90, 2.88), and malnutrition 2.46 (2.01, 3.01) when matched with those COVID-19 positive cancer patients without TL. Conclusions: Laryngeal and hypopharyngeal cancer patients had a higher rate of acquiring COVID-19 than patients without these cancers. TL patients have a higher rate of COVID-19 compared to those without TL and may be at a higher risk for sequalae of COVID-19.